Intratumoral Cisplatin for Resectable NSCLC

Clinical trial NCT04809103 · COMPLETED

Trial details

NCT number: NCT04809103
Sponsor: University of Vermont
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2021-03-08
Primary completion: 2025-10-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.